Livelsberger Financial Advisory Acadia Pharmaceuticals Inc Transaction History
Livelsberger Financial Advisory
- $6.7 Billion
- Q2 2024
Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
288Shares Held
161MCall Options Held
723KPut Options Held
257K-
Baker Bros. Advisors LP New York, NY42.9MShares$647 Million9.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.7MShares$207 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$207 Million3.72% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$182 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$87.6 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.44B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...